Bitter sweet: Fournier’s Gangrene and SGLT2 inhibitors
Diabetes mellitus, especially type 2 is becoming the biggest epidemic of the 21st century affecting more than 415 million adults globally and expected to increase to more than 640 million adults by 2040. Patients with diabetes are at high risk for adverse outcomes, notably cardiovascular disease wi...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Ottawa
2019-12-01
|
| Series: | University of Ottawa Journal of Medicine |
| Subjects: | |
| Online Access: | https://uottawa.scholarsportal.info/ottawa/index.php/uojm-jmuo/article/view/4476 |